Dozens Of States Probe Abilify Marketing

Law360, New York (April 28, 2009, 12:00 AM EDT) -- A 38-state coalition has launched an investigation into Bristol-Myers Squibb Co. for alleged violations of state consumer protection laws in its marketing of anti-psychotic Abilify.

In a 10-Q form filed Tuesday with the U.S. Securities and Exchange Commission, the company disclosed the existence of the multistate investigation into its marketing of Abilify, an anti-psychotic.

In March, Bristol-Myers received a letter from the Delaware Attorney General's Office notifying it of the investigation, it said in the filing.

Bristol-Myers did not disclose details of the investigation in the...
To view the full article, register now.